Zafer M.M.Amin M.ElMahallawy H.Ashour M.S.E.D.AlAgamy M.Department of Microbiology and ImmunologyFaculty of PharmacyAhram Canadian University4th Industrial ZoneBanks Complex6th of OctoberGizaEgypt; Department of Microbiology and ImmunologyFaculty of PharmacyCairo UniversityEl AiniAl Sayedah ZeinabCairoEgypt; Department of Clinical PathologyNational Cancer InstituteCairo UniversityCairoEgypt; Department of Microbiology and ImmunologyFaculty of PharmacyMSA University6th of OctoberGizaEgypt; Department of Microbiology and ImmunologyFaculty of PharmacyAl-Azhar UniversityCairoEgypt; Department of Pharmaceutics and MicrobiologyCollege of PharmacyKing Saud UniversityRiyadhSaudi Arabia2020-01-092020-01-09201412019712https://doi.org/10.1016/j.ijid.2014.07.008PubMed ID 25449240https://t.ly/rxpEWScopusThis work reports the occurrence of New Delhi metallo-beta-lactamase 1 (NDM-1) in metallo-beta-lactamase-producing Pseudomonas aeruginosa in Egypt for the first time, and the presence of more than one blaMBL gene in carbapenem-resistant P. aeruginosa. � 2014 The Authors.EnglishCarbapenem resistanceEgyptMetallo-beta-lactamasesNew Delhi metallo-beta-lactamase 1 (NDM-1)Pseudomonas aeruginosaVerona integron-encoded metallo-beta-lactamase (VIM-2)imipenemmeropenemmetallo beta lactamasemetallo beta lactamase 1unclassified drugbeta lactamasebeta-lactamase NDM-1agedantibiotic resistanceArticlebacterium isolatecase reportchromosome markerEgypthumanmaleminimum inhibitory concentrationmultilocus sequence typingnonhumanPseudomonas aeruginosaadultbiosynthesisdrug effectsenzymologygeneticsPseudomonas aeruginosayoung adultAdultAgedbeta-LactamasesDrug Resistance, BacterialEgyptHumansMalePseudomonas aeruginosaYoung AdultArticlehttps://doi.org/10.1016/j.ijid.2014.07.008PubMed ID 25449240